D-dimer comprises of two D fragments of the fibrin protein that get cross-linked after fibrinolysis of a blood clot, which is found in the human blood samples. The concentration of these D-dimers present in the patient blood samples help in the diagnosis of thrombosis. This test becomes very useful for those patients who are susceptible towards thrombotic disorders like venous thromboembolism.On the basis of disease diagnoses, the D-dimer market can be classified into three major segments namely, pulmonary embolism, deep venous thrombosis and others.
Request For Report Table of Content (TOC)@ https://www.persistencemarketresearch.com/toc/20632
Major driving factors for the growth of this market include, increasing prevalence of various cardiovascular and pulmonary diseases, rising incidence of heart strokes, pulmonary embolisms etc. and increasing demand for technologically advanced coagulation testing methods. Increasing prevalence of various cardiovascular and pulmonary diseases can cause life threatening problems, when accompanied by blood clots in the arterial or pulmonary pathway. Thus, the demand for D-dimer tests will augment, and hence will contribute towards the growth of the overall market. Technological advancement in these D-dimer tests will bring more revenues to this market in the coming future. Specific and more sensitive markers are now being used to make these tests more accurate and reliable, which now encompasses automated instrumentation which will further make these tests more standardized.
For comprehensive insights on keyword adoption, ask an analyst here@ https://www.persistencemarketresearch.com/ask-an-expert/20632
Geographically, North America dominates the D-dimer market followed by Europe. Major factors responsible for the dominance of these regions in this market are demand for advanced diagnostics for these life threatening blood clots inside human organ systems. Asia-Pacific region exhibited the fastest rate of growth due to increasing prevalence of cardiovascular diseases in the region combined with increasing affordability and awareness about these diagnostic tests. Some of the key players operating in this market are
- Abbott Laboratories, Inc.,
- Beckman Coulter Inc.,
- Bio/Data Corporation,
- Becton,
- Dickinson and Company,
- Corgenix, F.
- Hoffmann-La Roche Ltd., NANOGEN,
- Siemens Healthcare,
- Thermo Fischer Scientific, Inc.,
- Trinity Biotech plc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/20632
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
About us:
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Contact us:
Persistence Market Research
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com